Ninsun Biotech is a start-up based in Valais at BioArk. It operates in the field of oncology and is revolutionising the marking of cancer stem cells by offering, for the first time, a specific biomarker for several cancers, including lung, breast and colon. Current technologies rely on the use of a combination of non-specific markers, so Ninsun Biotech is breaking new ground with its patented technology, offering new prospects in terms of diagnosis, monitoring (companion tests) and, ultimately, individualised treatment for patients. Ninsun Biotech’s stem cell marking kits are also perfectly compatible with the current clinical chain of patient management.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Route De L'ile-Au-Bois, Monthey,valais 1870,switzerland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Monthey, Valais
Ninsun Biotech Questions
Ninsun Biotech's LinkedIn profile is https://ch.linkedin.com/company/ninsun-biotech
Ninsun Biotech has
2 employees.
View email and phone details for 2
employees at Ninsun Biotech.
Ninsun Biotech's industry is
Biotechnology Research
Ninsun Biotech's top competitors are
Immunskills Sa,
Stämm,
Bioark,
Excellgene Sa,
Novochizol Sa,
Bioalps - Swiss Health Valley,
Orio Therapeutics,
Rem Analytics,
Lonza,
Bioscibex.
Ninsun Biotech's categories are Biotechnology Research
Ninsun Biotech's founding year is 2025
